Novocol Pharmaceutical Of Canada is a finished-dose manufacturer based in Canada. It appears in 20 regulatory filings across 6 regulators, without an active US DMF or CEP on file. Its filings concentrate with Health Canada, EDE (AE) and SFDA (Saudi Arabia). Its GMP standing is certified by ANVISA (Brazil), MFDS (Korea) and US FDA. Its most recent recorded inspection, by US FDA, closed on 3 May 2024 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Cambridge, United Arab Emirates | Not on file |
| ONTARIO, Canada | Not on file |
| Canada, Canada | 3002807757 |
| Regulator | Filings | GMP certificates |
|---|---|---|
| Health Canada | 9 | None |
| EDE (AE) | 3 | None |
| SFDA (Saudi Arabia) | 3 | None |
| RCETH (BY) | 2 | None |
| NPRA (MY) | 2 | None |
| EDA (EG) | 1 | None |
| ANVISA (Brazil) | None | 2 |
| MFDS (Korea) | None | 2 |
| US FDA | None | 1 |
Choose your molecules and target markets. Novocol Pharmaceutical Of Canada comes back tiered against every other supplier able to file there.
Start for free